BRIAN BUHRER: Open Payments
NPI 1649931924 · AUSTIN, TX. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$2,725 in 97 payments from 23 companies in 2025. Trend: 2023 $1,335 · 2024 $2,064 · 2025 $2,725
Food & beverage: $2,622Education: $103
| Company | Payments | Amount |
|---|---|---|
| Janssen Biotech, Inc. | 19 | $791 |
| Teleflex LLC | 10 | $324 |
| ABBVIE INC. | 10 | $233 |
| Bayer Healthcare Pharmaceuticals Inc. | 7 | $161 |
| Olympus America Inc. | 7 | $156 |
| PFIZER INC. | 9 | $149 |
| Novartis Pharmaceuticals Corporation | 7 | $125 |
| Endo USA, Inc. | 1 | $122 |
| Dendreon Pharmaceuticals LLC | 3 | $99 |
| AstraZeneca Pharmaceuticals LP | 3 | $86 |
Products named: ERLEADA, BARRIGEL, RYBREVANT, BOTOX, XTANDI, Nubeqa, iTIND System, PLUVICTO.
Industry payments across TX — which companies pay providers there.
